http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2571350-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ea3215d4ccba707b78c4cf9133da5d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-43 |
| filingDate | 2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c24c2ee27febe7c06da499b350954a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbe7de5a57c555ed2f60b17e0106802 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f5180c4ad9f0be4e4beb6f16b1f6385 |
| publicationDate | 2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2571350-A1 |
| titleOfInvention | Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| abstract | The invention relates to a nucleic acid sequence that codes for peptides which inhibit the interaction of protein kinase A (PKA) and protein kinase A-anchor proteins (AKAP), a host organism, which has the nucleic acid sequence and, optionally, expresses the peptides. The invention also relates to the use of the peptides and of the host organism when studying diseases, which are associated with the AKAP PKA interaction, and to the use of the peptides as a pharmaceutical agent for treating diseases of this type. |
| priorityDate | 2004-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 948.